Herbas VPB

Print
EN | LT
LT - INITIAL TRIPLE COMBINATION THERAPY WITH MACITENTAN, TADALAFIL, AND SELEXIPAG FOR TREATING PULMONARY ARTERIAL HYPERTENSION
EN - INITIAL TRIPLE COMBINATION THERAPY WITH MACITENTAN, TADALAFIL, AND SELEXIPAG FOR TREATING PULMONARY ARTERIAL HYPERTENSION

Legal status

Patent not validated

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/4965 (2006.01)
A61K 31/4985 (2013.01)
A61K 31/4985 (2006.01)
A61K 31/4965 (2013.01)
A61K 31/505 (2006.01)
A61K 31/53 (2013.01)
A61K 31/506 (2006.01)
A61K 31/519 (2013.01)
A61K 31/519 (2006.01)
A61K 31/505 (2013.01)
A61K 31/53 (2006.01)
A61K 31/506 (2013.01)
A61P 9/12 (2006.01)
A61P 9/12 (2018.01)
A61K 45/06 (2006.01)
A61K 45/06 (2013.01)
Y02A 50/30 (2018.01)
European patent
(11) Number of the document 4065119
(13) Kind of document T
(96) European patent application number 20820054.3
Date of filing the European patent application 2020-11-27
(97) Date of publication of the European application 2022-10-05
(45) Date of publication and mention of the grant of the patent 2024-09-04
(46) Date of publication of the claims translation
PCT application
(86) Number PCT/EP2020/083593
Date 2020-11-27
PCT application publication
(87) Number WO 2021/105331
Date 2021-06-03
Priority applications
(30) Number Date Country code
201962941910 P 2019-11-29 US
202063023452 P 2020-05-12 US
202063076149 P 2020-09-09 US
Inventors
(72)
MARESTA, Alessandro , CH
PERCHENET, Loïc , CH
Grantee
(73) Actelion Pharmaceuticals Ltd , Gewerbestrasse 16, 4123 Allschwil, CH
Title
(54) INITIAL TRIPLE COMBINATION THERAPY WITH MACITENTAN, TADALAFIL, AND SELEXIPAG FOR TREATING PULMONARY ARTERIAL HYPERTENSION
  INITIAL TRIPLE COMBINATION THERAPY WITH MACITENTAN, TADALAFIL, AND SELEXIPAG FOR TREATING PULMONARY ARTERIAL HYPERTENSION